Rare Cancer News & Clinical Trials » Trials

Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)

Posted: April 24th, 2017, 10:00am EDT

Conditions: Radiation Therapy; Cancer; Cancer of Anus; Cancer of Bladder; Cancer of Cervix; Cancer of Colon; Cancer of Rectum; Cancer of Esophagus; Cancer of Gallbladder; Cancer of Liver; Cancer of Ovary; Cancer of Pancreas; Cancer of Prostate; Cancer of Kidney and Renal Pelvis; Cancer of Stomach; Cancer of Testis; Cancer of Uterus; Cancer of Uterus and Cervix; Cancer of Kidney
Intervention:
Sponsors: DxTerity Diagnostics; National Cancer Institute (NCI)
Recruiting - verified May 2017

Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer

Posted: March 16th, 2017, 10:00am EDT

Condition: Biliary Tract Cancer
Interventions: Drug: Varlitinib; Drug: Capecitabine; Drug: Placebo (for Varlitinib)
Sponsor: Aslan Pharmaceuticals
Not yet recruiting - verified March 2017

Permalink for 'Nal-IRI and 5-FU Compared to 5-FU in Patients With Cholangio- and Gallbladder Carcinoma Previously Treated With Gemcitabine-based Therapies'

Nal-IRI and 5-FU Compared to 5-FU in Patients With Cholangio- and Gallbladder Carcinoma Previously Treated With Gemcitabine-based Therapies

Posted: January 26th, 2017, 10:00am EST

Conditions: Cholangiocarcinoma Non-resectable; Cholangiocarcinoma Metastatic; Cholangiocarcinoma of the Gallbladder; Cholangiocarcinoma Advanced
Interventions: Drug: nal-IRI; Drug: 5-FU; Drug: leucovorin
Sponsors: AIO-Studien-gGmbH; Shire
Not yet recruiting - verified June 2017

A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers

Posted: October 2nd, 2016, 10:00am EDT

Conditions: Gastrointestinal Cancer; Neuroendocrine Tumours; Malignant Female Reproductive System Neoplasm
Interventions: Drug: Ipilimumab; Drug: Nivolumab
Sponsors: Olivia Newton-John Cancer Research Institute; Bristol-Myers Squibb
Not yet recruiting - verified April 2017

Point of Care 3D Ultrasound for Various Applications: A Pilot Study

Posted: July 11th, 2016, 10:00am EDT

Conditions: Appendicitis; Evidence of Cholecystectomy; Gallstones; Pregnancy, Ectopic; Aortic Aneurysm; Kidney Stones; Intrauterine Pregnancy; Diverticulitis; Abdominal Injuries; Tumors; Pancreatitis; Digestive System Diseases; Gastrointestinal Diseases; Intraabdominal Infections; Intestinal Diseases; Pregnancy; Vascular Disease; Uterine Fibroids; Ovarian Cysts; Uterine Abnominalies; Bladder Abnominalies; Testicular Abnominalies; Polyps
Intervention:
Sponsors: Duke University; Wallace H. Coulter Foundation
Recruiting - verified March 2017

Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery

Posted: June 6th, 2016, 10:00am EDT

Conditions: Cholecystitis; Endometriosis; Bowel Obstruction; Fibroids; Prostate Cancer; Chronic Kidney Disease; Uterine Prolapse
Interventions: Procedure: deep neuromuscular blockade; Procedure: moderate neuromuscular blockade; Drug: Rocuronium
Sponsors: Stony Brook University; Merck Sharp & Dohme Corp.
Recruiting - verified April 2017

Superior Bilioenteric Anastomosis by Magnetic Compressive Technique

Posted: May 29th, 2016, 10:00am EDT

Conditions: Hilar Cholangiocarcinoma; Bile Duct Injury; Choledochal Cyst; Biliary Calculi
Interventions: Device: Magnetic Compressive Anastomosis; Procedure: Manual Anastomosis
Sponsors: First Affiliated Hospital Xi'an Jiaotong University; Shaanxi Provincial People's Hospital; Tang-Du Hospital; First Affiliated Hospital, Sun Yat-Sen University; First Affiliated Hospital of Xinjiang Medical University; General Hospital of Ningxia Medical University
Not yet recruiting - verified June 2017

Chile Biliary Longitudinal Study

Posted: February 25th, 2016, 10:00am EST

Conditions: Gallbladder Cancer; Nutritional and Metabolic Diseases
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - verified June 14, 2017

Ramucirumab for Advanced Pre-Treated Biliary Cancers

Posted: August 5th, 2015, 10:00am EDT

Condition: Biliary Cancer
Intervention: Drug: Ramucirumab
Sponsors: M.D. Anderson Cancer Center; Eli Lilly and Company
Recruiting - verified June 2017

Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer

Posted: October 9th, 2014, 10:00am EDT

Conditions: Breast Cancer; Colon Cancer; Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastrointestinal Cancer; Liver and Intrahepatic Biliary Tract Cancer; Lung Cancer; Metastatic Cancer; Pancreatic Cancer; Rectal Cancer; Thyroid Gland Medullary Carcinoma; Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Procedure: radionuclide imaging; Procedure: positron emission tomography; Other: laboratory biomarker analysis; Other: pharmacological study; Drug: Cu 64 anti-CEA monoclonal antibody M5A IV
Sponsors: City of Hope Medical Center; National Cancer Institute (NCI)
Recruiting - verified March 2017

Los Angeles Prospective GI Biliary and EUS Series

Posted: July 19th, 2014, 10:00am EDT

Conditions: Biliary Disease; Pancreatitis; Gastrointestinal Neoplasms
Intervention: Other: clinical course
Sponsor: University of Southern California
Recruiting - verified April 2017

Permalink for 'Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Observation After Curative Intent Resection of Biliary Tract Cancer'

Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Observation After Curative Intent Resection of Biliary Tract Cancer

Posted: June 18th, 2014, 10:00am EDT

Conditions: Cholangiocarcinoma; Gall Bladder Carcinoma
Interventions: Drug: Gemcitabine; Drug: Cisplatin; Other: Observation
Sponsors: Universitätsklinikum Hamburg-Eppendorf; Deutsche Krebshilfe e.V., Bonn (Germany); medac GmbH; Cancer Research UK; AGITG Australasian Gastro Intestinal Trials Group; KWF Kanker Bestrijding The Netherlands
Recruiting - verified March 2017

$Permalink for 'Single Agent Regorafenib in Refractory Advanced Biliary Cancers'$

Single Agent Regorafenib in Refractory Advanced Biliary Cancers

Posted: April 11th, 2014, 10:00am EDT

Condition: Cancer of the Bile Duct
Intervention: Drug: Regorafenib
Sponsors: H. Lee Moffitt Cancer Center and Research Institute; Bayer
Recruiting - verified March 2017

Integrated Cancer Repository for Cancer Research

Posted: December 2nd, 2013, 10:00am EST

Conditions: Pancreatic Cancer; Thyroid Cancer; Lung Cancer; Esophageal Cancer; Thymus Cancer; Colon Cancer; Rectal Cancer; GIST; Anal Cancer; Bile Duct Cancer; Duodenal Cancer; Gallbladder Cancer; Gastric Cancer; Liver Cancer; Small Intestine Cancer; Peritoneal Surface Malignancies; Familial Adenomatous Polyposis; Lynch Syndrome; Bladder Cancer; Kidney Cancer; Penile Cancer; Prostate Cancer; Testicular Cancer; Ureter Cancer; Urethral Cancer; Hypopharyngeal Cancer; Laryngeal Cancer; Lip Cancer; Oral Cavity Cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer; Paranasal Sinus Cancer; Nasal Cavity Cancer; Salivary Gland Cancer; Skin Cancer; CNS Tumor; CNS Cancer; Mesothelioma; Breastcancer; Leukemia; Melanoma; Sarcoma; Unknown Primary Tumor; Multiple Myeloma; Ovarian Cancer; Endometrial Cancer; Vaginal Cancer
Intervention:
Sponsor: University of Nebraska
Recruiting - verified May 2017

CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery

Posted: January 10th, 2013, 10:00am EST

Conditions: Adult Primary Cholangiocellular Carcinoma; Advanced Adult Primary Liver Cancer; Cholangiocarcinoma of the Extrahepatic Bile Duct; Cholangiocarcinoma of the Gallbladder; Localized Unresectable Adult Primary Liver Cancer; Metastatic Extrahepatic Bile Duct Cancer; Recurrent Adult Primary Liver Cancer; Recurrent Extrahepatic Bile Duct Cancer; Unresectable Extrahepatic Bile Duct Cancer
Intervention: Drug: 6,8-bis(benzylthio)octanoic acid
Sponsors: Wake Forest University Health Sciences; National Cancer Institute (NCI)
Recruiting - verified March 2017

Permalink for 'Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies'

Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies

Posted: July 16th, 2012, 10:00am EDT

Conditions: Acinar Cell Adenocarcinoma of the Pancreas; Adenocarcinoma of the Gallbladder; Adenocarcinoma of Unknown Primary; Adult Primary Cholangiocellular Carcinoma; Advanced Adult Primary Liver Cancer; Cholangiocarcinoma of the Extrahepatic Bile Duct; Cholangiocarcinoma of the Gallbladder; Diffuse Adenocarcinoma of the Stomach; Duct Cell Adenocarcinoma of the Pancreas; Intestinal Adenocarcinoma of the Stomach; Localized Unresectable Adult Primary Liver Cancer; Metastatic Carcinoma of Unknown Primary; Metastatic Extrahepatic Bile Duct Cancer; Mixed Adenocarcinoma of the Stomach; Mucinous Adenocarcinoma of the Colon; Mucinous Adenocarcinoma of the Rectum; Newly Diagnosed Carcinoma of Unknown Primary; Signet Ring Adenocarcinoma of the Colon; Signet Ring Adenocarcinoma of the Rectum; Stage III Pancreatic Cancer; Stage IIIA Colon Cancer; Stage IIIA Gallbladder Cancer; Stage IIIA Gastric Cancer; Stage IIIA Rectal Cancer; Stage IIIB Colon Cancer; Stage IIIB Gallbladder Cancer; Stage IIIB Gastric Cancer; Stage IIIB Rectal Cancer; Stage IIIC Colon Cancer; Stage IIIC Gastric Cancer; Stage IIIC Rectal Cancer; Stage IV Gastric Cancer; Stage IV Pancreatic Cancer; Stage IVA Colon Cancer; Stage IVA Gallbladder Cancer; Stage IVA Rectal Cancer; Stage IVB Colon Cancer; Stage IVB Gallbladder Cancer; Stage IVB Rectal Cancer; Unresectable Extrahepatic Bile Duct Cancer
Interventions: Drug: oxaliplatin; Drug: irinotecan hydrochloride; Drug: leucovorin calcium; Drug: fluorouracil; Other: laboratory biomarker analysis
Sponsors: University of Chicago; National Cancer Institute (NCI)
Recruiting - verified April 2017

Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer

Posted: March 10th, 2011, 10:00am EST

Conditions: Gastrointestinal Neoplasms; Cancer of Gastrointestinal Tract; Cancer of the Gastrointestinal Tract; Gastrointestinal Cancer; Neoplasms, Gastrointestinal
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting - verified May 23, 2017

Rare Cancer News & Clinical Trials » Trials - Gall Bladder Cancer

Feeds

Trials - Gall Bladder Cancer (17 unread)